The mitochondrial DNA common deletion as a potential biomarker of cancer-associated fibroblasts from skin basal and squamous cell carcinomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The mitochondrial DNA common deletion as a potential biomarker of cancer-associated fibroblasts from skin basal and squamous cell carcinomas ; volume:14 ; number:1 ; day:4 ; month:1 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (4.1.2024), 1-14, 12.2024
- Creator
-
Fontana, Gabriele A.
MacArthur, Michael R.
Rotankova, Nadezhda
Di Filippo, Michela
Beer, Hans-Dietmar
Gahlon, Hailey
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-50213-1
- URN
-
urn:nbn:de:101:1-2024031910562953808708
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fontana, Gabriele A.
- MacArthur, Michael R.
- Rotankova, Nadezhda
- Di Filippo, Michela
- Beer, Hans-Dietmar
- Gahlon, Hailey
- SpringerLink (Online service)
Other Objects (12)
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts
Biomarkers for cancer-associated fibroblasts
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
Advances of cancer-associated fibroblasts in liver cancer
Comparative transcriptome of normal and cancer-associated fibroblasts
SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities